During the meeting, Dr. Clarissa Hsu, Associate Investigator, with the Kaiser Permanente Washington Health Research Institute, and Janice Tufte, Patient Co-Investigator, presented their article entitled, "Evaluation of the Learning to Integrate Neighborhoods and Clinical Care Project: Findings from Implementing a New Lay Role into Primary Care Teams to Address Social Determinants of Health." In addition, Dr. Scott Strayer, Chair of the Department of Family Medicine at Virginia Commonwealth University, presented the article, "Preventing colorectal cancer or early diagnosis: Which is best? A re-analysis of the U.S. Preventive Services Task Force Evidence Report."
The objective of the study was to assess the implementation and impact of the Community Resource Specialist (CRS) role in Kaiser Permanente Washington.
The Community Resource Specialist Role from KP Washington Research on Vimeo.
CRS Qualifications:
Role Implementation
Practice/Policy Implications:
Janice Tufte (Patient-Co-Investigator) Reaction:
Colon cancer is still one of the leading causes of death in the United States, yet it is very preventable if people get screened. Flexible sigmoidoscopy (FS) is the only cancer screening test to lower the risk of death compared to usual care in randomized controlled trials (RCTs).
The study suggests prevention of CRC appears to be the major (or sole) mechanism of action for death reduction by FS in clinical trials. Conversely, early diagnosis of CRC does not appear to reduce death. In other words, if you reduce the incidence of colon cancer by one case, you're going to reduce death by one case.
Overall, the best test is the one that people are going to get.